Your browser doesn't support javascript.
loading
Body mass index as a predictor of MS activity and progression among participants in BENEFIT.
Manuel Escobar, Juan; Cortese, Marianna; Edan, Gilles; Freedman, Mark S; Hartung, Hans-Peter; Montalbán, Xavier; Sandbrink, Rupert; Radü, E-W; Barkhof, Frederik; Wicklein, Eva-Maria; Kappos, Ludwig; Ascherio, Alberto; Munger, Kassandra L.
Afiliação
  • Manuel Escobar J; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA/Department of Neurology, La Paz University Hospital, Madrid, Spain.
  • Cortese M; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Edan G; CHU Hôpital Pontchaillou, Rennes, France.
  • Freedman MS; University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine-Universität, Düsseldorf, Germany.
  • Montalbán X; Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain.
  • Sandbrink R; Topas Therapeutics GmbH, Hamburg, Germany/VICO Therapeutics, Leiden, The Netherlands.
  • Radü EW; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Barkhof F; Institute of Neurology, University College London, London, UK.
  • Wicklein EM; Bayer AG, Berlin, Germany.
  • Kappos L; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Ascherio A; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA/Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA/Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, M
  • Munger KL; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Mult Scler ; 28(8): 1277-1285, 2022 07.
Article em En | MEDLINE | ID: mdl-34994579

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha